Futura Medical (FUM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Futura Medical (FUM) has a cash flow conversion efficiency ratio of -0.940x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.64 Million ≈ $-320.73 USD) by net assets (GBX2.81 Million ≈ $341.31 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Futura Medical for the company's overall valuation and market capitalisation.
Futura Medical - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Futura Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Futura Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Futura Medical ranked by their cash flow conversion efficiency. Explore Futura Medical cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fantasy Network Ltd
TA:FNTS
|
-0.069x |
|
Hana Microelectronics Public Company Limited
F:HAA1
|
0.055x |
|
Meren Energy Inc.
TO:MER
|
0.166x |
|
Sabien Technology Group Plc
LSE:SNT
|
0.043x |
|
Orient Europharma Co Ltd
TWO:4120
|
-0.020x |
|
iLearningEngines, Inc.
NASDAQ:AILEQ
|
-3.216x |
|
PTT Global Chemical Public Company Limited
F:GCB
|
-0.057x |
|
Distil Plc
LSE:DIS
|
-0.129x |
Annual Cash Flow Conversion Efficiency for Futura Medical (2001–2025)
The table below shows the annual cash flow conversion efficiency of Futura Medical from 2001 to 2025. View Futura Medical (FUM) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX2.81 Million ≈ $341.31 |
GBX-5.58 Million ≈ $-678.54 |
-1.988x | -4164.32% |
| 2024-12-31 | GBX8.96 Million ≈ $1.09K |
GBX438.41K ≈ $53.34 |
0.049x | -53.02% |
| 2023-12-31 | GBX5.48 Million ≈ $666.37 |
GBX570.25K ≈ $69.38 |
0.104x | +108.51% |
| 2022-12-31 | GBX4.72 Million ≈ $574.23 |
GBX-5.78 Million ≈ $-702.69 |
-1.224x | -207.24% |
| 2021-12-31 | GBX9.72 Million ≈ $1.18K |
GBX-3.87 Million ≈ $-471.26 |
-0.398x | +92.52% |
| 2020-12-31 | GBX853.54K ≈ $103.85 |
GBX-4.54 Million ≈ $-552.79 |
-5.323x | +95.71% |
| 2019-12-31 | GBX53.65K ≈ $6.53 |
GBX-6.66 Million ≈ $-809.87 |
-124.063x | -23226.94% |
| 2018-12-31 | GBX8.85 Million ≈ $1.08K |
GBX-4.71 Million ≈ $-572.83 |
-0.532x | -16.00% |
| 2017-12-31 | GBX9.11 Million ≈ $1.11K |
GBX-4.17 Million ≈ $-507.95 |
-0.458x | -74.94% |
| 2016-12-31 | GBX12.58 Million ≈ $1.53K |
GBX-3.30 Million ≈ $-401.27 |
-0.262x | +76.61% |
| 2015-12-31 | GBX4.79 Million ≈ $582.35 |
GBX-5.36 Million ≈ $-652.63 |
-1.121x | -255.27% |
| 2014-12-31 | GBX9.72 Million ≈ $1.18K |
GBX-3.07 Million ≈ $-373.13 |
-0.315x | +84.53% |
| 2013-12-31 | GBX987.77K ≈ $120.18 |
GBX-2.01 Million ≈ $-245.04 |
-2.039x | -201.85% |
| 2012-12-31 | GBX2.87 Million ≈ $349.59 |
GBX-1.94 Million ≈ $-236.14 |
-0.675x | -1.47% |
| 2011-12-31 | GBX2.76 Million ≈ $335.57 |
GBX-1.84 Million ≈ $-223.39 |
-0.666x | +42.71% |
| 2010-12-31 | GBX901.00K ≈ $109.63 |
GBX-1.05 Million ≈ $-127.39 |
-1.162x | -63.37% |
| 2009-12-31 | GBX1.85 Million ≈ $225.46 |
GBX-1.32 Million ≈ $-160.36 |
-0.711x | +68.03% |
| 2008-12-31 | GBX886.00K ≈ $107.80 |
GBX-1.97 Million ≈ $-239.81 |
-2.225x | -170.33% |
| 2007-12-31 | GBX2.77 Million ≈ $337.39 |
GBX-2.28 Million ≈ $-277.65 |
-0.823x | -75.43% |
| 2006-12-31 | GBX3.95 Million ≈ $480.36 |
GBX-1.85 Million ≈ $-225.33 |
-0.469x | +56.29% |
| 2005-12-31 | GBX1.98 Million ≈ $240.91 |
GBX-2.12 Million ≈ $-258.55 |
-1.073x | -177.22% |
| 2004-12-31 | GBX3.75 Million ≈ $456.02 |
GBX-1.45 Million ≈ $-176.54 |
-0.387x | +31.27% |
| 2003-12-31 | GBX2.41 Million ≈ $293.11 |
GBX-1.36 Million ≈ $-165.11 |
-0.563x | +19.43% |
| 2003-01-31 | GBX1.52 Million ≈ $184.82 |
GBX-1.06 Million ≈ $-129.21 |
-0.699x | -8.85% |
| 2002-01-31 | GBX2.00 Million ≈ $243.22 |
GBX-1.28 Million ≈ $-156.23 |
-0.642x | -159.76% |
| 2001-01-31 | GBX-294.00K ≈ $-35.77 |
GBX-316.00K ≈ $-38.45 |
1.075x | -- |
About Futura Medical
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more